99 related articles for article (PubMed ID: 8016059)
1. [A comparative evaluation of the effect of glurenorm and sulfonylurea preparations on the intravascular microcirculatory indices in type-II diabetes mellitus].
Kakhnovskiĭ IM; Koroleva TV; Zakharchenko VN; Larionov SN
Probl Endokrinol (Mosk); 1993; 39(2):7-9. PubMed ID: 8016059
[TBL] [Abstract][Full Text] [Related]
2. [Use of glipizide and evaluation of its effect on microcirculation in patients with diabetes mellitus type 2].
Spesivtseva VG; Golubiatnikova GA; Koroleva TV; Pokryshkin VI; Anisimova VN
Probl Endokrinol (Mosk); 1987; 33(6):10-3. PubMed ID: 3438260
[TBL] [Abstract][Full Text] [Related]
3. [Experience with diamicron treatment of diabetics].
Velikov VK; Shubina IO; Saltykov BB; Frolova AI
Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
[No Abstract] [Full Text] [Related]
4. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
Grzeszczak W; Strojek K
Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
[No Abstract] [Full Text] [Related]
5. The effects of glurenorm on plasma glucose and lipids in patients with type 2 diabetes mellitus.
Chou SC; Chen KW; Huang CC; Lin KD; Hwang JS; Lin JD
Chang Gung Med J; 2000 Aug; 23(8):480-4. PubMed ID: 11039250
[TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
Borisova AM; Taneva T; Koev D; Georgieva R
Vutr Boles; 1988; 27(2):85-9. PubMed ID: 3137730
[TBL] [Abstract][Full Text] [Related]
7. [Effect of sugar-reducing therapy on renal function in patients with type II diabetes mellitus].
Mazurov VI; Novik AA; Nagibovich OA; Romashevskiĭ BV; Guliaeva IV; Kurganova TA
Klin Med (Mosk); 1998; 76(6):38-41. PubMed ID: 9693499
[TBL] [Abstract][Full Text] [Related]
8. [Our experience in treating diabetes mellitus with the preparation Minidiab].
Tsanev A; Lazarov G; Manolov D; Daskalova I; Kolebinov N
Vutr Boles; 1988; 27(2):89-93. PubMed ID: 3414105
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
Rybka J; Gregorová A; Zmydlená A
Vnitr Lek; 1988 Aug; 34(8):786-92. PubMed ID: 3176368
[No Abstract] [Full Text] [Related]
10. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
Masbernard A; Portal A
Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
[No Abstract] [Full Text] [Related]
11. [Effect of insulin and sulfonylurea derivatives on chronic intravascular microcoagulation of the blood in diabetes mellitus].
Velikov VK; Galkina AK; Bokarev IN; Frolova AI; Shubina OI
Sov Med; 1985; (9):91-3. PubMed ID: 3906934
[No Abstract] [Full Text] [Related]
12. [The use of the hypoglycemic preparation gliquidone in patients with digestive organ diseases combined with diabetes mellitus].
Degtiareva II; Lodianaia EV; Opanasiuk ND; Palladina OL
Lik Sprava; 1995; (7-8):84-7. PubMed ID: 8846383
[TBL] [Abstract][Full Text] [Related]
13. [Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds].
Grujić M; Rizvanbegović B; Perinović M; Perinović ID
Med Arh; 1976; 30(2):119-21. PubMed ID: 971371
[No Abstract] [Full Text] [Related]
14. [Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts].
Balabolkin MI; Nedosugova LV
Probl Endokrinol (Mosk); 1993; 39(4):16-8. PubMed ID: 8415521
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter study with gliquidone in type 2 diabetes mellitus].
Kreze A; Vozár J; Rázus P; Lacko A; Málek Z; Putz Z
Vnitr Lek; 1991; 37(9-10):761-7. PubMed ID: 1771808
[TBL] [Abstract][Full Text] [Related]
16. [The use of rheopolyglucin in diabetic patients with a microcirculatory disorder].
Zhumatova MG
Ter Arkh; 1991; 63(10):49-51. PubMed ID: 1725224
[No Abstract] [Full Text] [Related]
17. [Use of glurenorm in patients with non-insulin-dependent diabetes mellitus and liver diseases].
Dedov II; Demidova IIu; Pisklakov SV; Antokhin EA
Probl Endokrinol (Mosk); 1993; 39(3):6-8. PubMed ID: 8058688
[TBL] [Abstract][Full Text] [Related]
18. [Combined therapy with insulin/gliquidone (Glurenorm) in type 2 diabetes after treatment failure using oral antidiabetic agents].
Podrouzková B; Krusová D
Vnitr Lek; 1992 Oct; 38(10):963-7. PubMed ID: 1481374
[TBL] [Abstract][Full Text] [Related]
19. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
[TBL] [Abstract][Full Text] [Related]
20. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
